Grupo Metabolismo y Nutrición, IDIPHIM, Spain; Unidad de Vitaminas, Spain; Servicio de Bioquímica Clínica, Hospital Universitario Puerta de Hierro-Majadahonda, 28222 Madrid, Spain.
Grupo Metabolismo y Nutrición, IDIPHIM, Spain; Unidad de Vitaminas, Spain; Servicio de Bioquímica Clínica, Hospital Universitario Puerta de Hierro-Majadahonda, 28222 Madrid, Spain.
Food Res Int. 2017 Sep;99(Pt 2):902-916. doi: 10.1016/j.foodres.2017.03.036. Epub 2017 Mar 24.
The use of biomarkers constitutes an essential tool to assess the bioavailability of carotenoids in humans. The present article aims to review several methodological, host-related and modulating factors relevant on assessing and interpreting carotenoid bioavailability. Markers for carotenoid bioavailability can be broadly divided into direct, biochemical or "analytical" markers and indirect, physiological or "functional" indicators. Analytical markers usually refer to biochemical indicators of intake and/or status (short and long term exposure) while functional measures may be interpreted in terms of cumulative exposure, biological effect (bioactivity) or modification of risk factors. Both types of markers display advantages and limitations but, in general, a relationship exists among the type of marker, the biological specimen needed and the time required for a change. Humans may absorb a wide range of carotenes and xanthophylls and many of them may be found in serum and tissues. However, under physiological conditions, the several classes of dietary carotenoids may behave unequally leading to a different systemic profile and, moreover, they can be selectively accumulated at target tissues. In addition, some carotenoids may be chemically and enzymatically modified generating different oxidative metabolites and apocarotenoids. Quantitatively, the biological response upon carotenoid intervention (assessed by analytical and functional markers) is highly variable but the use of large doses and long-term protocols may lead to saturation effects and the loss of linearity in the response. Also, despite carotenoid exposition is considered to be safe, markers of overexposure include clinical signs (i.e. carotenodermia, corneal rings and retinopathy) and biochemical indicators (hypercarotenemia, xanthophyll esters). Overall, both host-related and methodological factors may influence analytical and functional markers to assess carotenoid bioavailability although the different subclasses of carotenoids may not be equally affected.
生物标志物的使用是评估类胡萝卜素在人体中生物利用度的重要工具。本文旨在综述评估和解释类胡萝卜素生物利用度时涉及的几种方法学、宿主相关和调节因素。生物标志物可广泛分为直接的、生化的或“分析”标志物和间接的、生理的或“功能”指标。分析标志物通常是指摄入量和/或状态(短期和长期暴露)的生化指标,而功能测量可以根据累积暴露、生物学效应(生物活性)或危险因素的改变来解释。这两种类型的标志物都有其优点和局限性,但一般来说,标志物的类型、所需的生物样本和发生变化所需的时间之间存在着一定的关系。人类可能吸收多种类胡萝卜素和叶黄素,其中许多类胡萝卜素和叶黄素可在血清和组织中发现。然而,在生理条件下,几种类胡萝卜素可能表现出不同的行为,导致不同的系统特征,而且它们可以选择性地在靶组织中积累。此外,一些类胡萝卜素可能会发生化学和酶促修饰,生成不同的氧化代谢物和脱辅基类胡萝卜素。从数量上看,类胡萝卜素干预后的生物学反应(通过分析和功能标志物评估)具有很大的可变性,但使用大剂量和长期方案可能会导致饱和效应和反应的线性丧失。此外,尽管类胡萝卜素暴露被认为是安全的,但过度暴露的标志物包括临床症状(如胡萝卜素沉着、角膜环和视网膜病变)和生化指标(高胡萝卜素血症、叶黄素酯)。总的来说,宿主相关和方法学因素都可能影响评估类胡萝卜素生物利用度的分析和功能标志物,尽管不同的类胡萝卜素亚类可能不会受到同等影响。